Investigating the basis of immune-related adverse events caused by checkpoint inhibitor immunotherapy
Investigating the basis of immune-related adverse events caused by checkpoint inhibitor immunotherapy
调查检查点抑制剂免疫治疗引起的免疫相关不良事件的基础
批准号：
474218
负责人：
Yao Jing Yuan
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-10-01 至 2025-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, achieving remarkably durable responses in a subset of patients. By blocking various cell surface molecules that inhibit immune cell function, ICIs potentiate tumour-reactive T cells
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
